We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Dispensed Opioid, Buprenorphine, Benzodiazepine, and Stimulant Prescriptions among Rhode Island Residents, 2017-2021.
- Authors
PAIVA, TAYLOR J.; NITENSON, ADAM Z.; ANTINOZZI, DANA; ONYEJEKWE, COLLETTE; MCDONALD, JAMES V.; HALLOWELL, BENJAMIN D.
- Abstract
The Rhode Island Prescription Drug Monitoring Program (PDMP) requires dispensers with an active Controlled Substance Registration to report Schedule II-V substances and opioid antagonists within 24 hours of dispensing. This database was designed to surveille diversion and identify high-risk prescribing to prevent drug related harms. Using PDMP data from January 1, 2017, to December 31, 2021, opioid, buprenorphine, stimulant, and benzodiazepine dispensing trends were explored. During this time, opioid prescriptions dispensed annually decreased by 27.3% (from 576,421 to 419,220), and benzodiazepine prescriptions dispensed annually decreased by 12.3% (552,430 to 484,496). High-risk prescribing also decreased with opioids prescriptions > 90 daily MME decreasing by 52.1% and instances of overlapping benzodiazepine and opioid prescriptions decreasing by 34.1%. Buprenorphine and stimulant dispensing have increased by 11.1% and 20.7%, respectively. Prevention interventions will continue to educate providers on appropriate prescribing practices and work to further reduce unnecessary prescribing within the state.
- Subjects
RHODE Island; INAPPROPRIATE prescribing (Medicine); STIMULANTS; CONTROLLED substances; BUPRENORPHINE; MEDICAL prescriptions
- Publication
Rhode Island Medical Journal, 2023, Vol 106, Issue 2, p27
- ISSN
0363-7913
- Publication type
Article